Literature DB >> 17261243

[Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results].

Ana María Caro-Murillo1, Jesús Castilla, Santiago Pérez-Hoyos, José M Miró, Daniel Podzamczer, Rafael Rubio, Melchor Riera, Pompeyo Viciana, José López Aldeguer, José Antonio Iribarren, Ignacio de los Santos-Gil, Juan Luis Gómez-Sirvent, Juan Berenguer, Félix Gutiérrez, María Saumoy, Ferrán Segura, Vicente Soriano, Alejandro Peña, Federico Pulido, José Antonio Oteo, Manuel Leal, Jordi Casabona, Julia del Amo, Santiago Moreno.   

Abstract

OBJECTIVE: To describe the methodology and baseline results of the Spanish cohort of naïve HIV-infected patients included in the Research Network on HIV/AIDS (CoRIS).
METHODS: CoRIS is a multicenter, hospital-based prospective cohort of HIV sero-prevalent, retroviral-naïve subjects, over 13 years old, and seen at 17 hospitals in 8 of the 17 Autonomous Regions in Spain from January 2004 to October 2005. The socio-demographic characteristics, as well as epidemiological, clinical, laboratory and treatment data were recorded, and biological samples were collected at baseline and during follow-up.
RESULTS: A total of 1,591 subjects have been included in CoRIS; 24% are women, median age at cohort entry is 36 years, and 74% were diagnosed during 2004 or 2005. Twenty-seven percent came from countries other than Spain, mainly Latin-America (16%) and sub-Saharan Africa (5%). Thirty-two percent had completed secondary education and 16% university studies. The most frequent categories of transmission were men having sex with men (37%) and heterosexual sex (36%); only 21% were injection drug users. At cohort entry, median CD4 count was 317 cells/mm 3 and median viral load was 52,300 copies/mL; 18% were diagnosed with AIDS. Main AIDS-defining illnesses were Pneumocystis jiroveci pneumonia (6.1%), esophageal candidiasis (3.3%) and tuberculosis (extrapulmonary, 3.0% and pulmonary 2.7%). There were 35 deaths (2.2%). Thirty-three percent of patients gave a baseline sample to the BioBank.
CONCLUSIONS: CoRIS offers relevant information about the current epidemiological profile of HIV infection in Spain, where sexual transmission has become predominant. The type and amount of information obtained from clinical and epidemiological data collection together with biological samples demonstrate the viability of the project, which offers many possibilities for future research.

Entities:  

Mesh:

Year:  2007        PMID: 17261243     DOI: 10.1157/13096749

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  28 in total

1.  Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses.

Authors:  Gonzalo Yebra; Miguel de Mulder; Leticia Martín; Carmen Rodríguez; Pablo Labarga; Isabel Viciana; Juan Berenguer; María Remedios Alemán; Juan Antonio Pineda; Federico García; Africa Holguín
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

2.  Morphine modulation of toll-like receptors in microglial cells potentiates neuropathogenesis in a HIV-1 model of coinfection with pneumococcal pneumoniae.

Authors:  Raini Dutta; Anitha Krishnan; Jingjing Meng; Subash Das; Jing Ma; Santanu Banerjee; Jinghua Wang; Richard Charboneau; Om Prakash; Roderick A Barke; Sabita Roy
Journal:  J Neurosci       Date:  2012-07-18       Impact factor: 6.167

3.  Ensemble learning of inverse probability weights for marginal structural modeling in large observational datasets.

Authors:  Susan Gruber; Roger W Logan; Inmaculada Jarrín; Susana Monge; Miguel A Hernán
Journal:  Stat Med       Date:  2014-10-15       Impact factor: 2.373

4.  Definition of advanced age in HIV infection: looking for an age cut-off.

Authors:  José R Blanco; Inmaculada Jarrín; Manuel Vallejo; Juan Berenguer; Carmen Solera; Rafael Rubio; Federico Pulido; Victor Asensi; Julia del Amo; Santiago Moreno
Journal:  AIDS Res Hum Retroviruses       Date:  2012-09       Impact factor: 2.205

5.  Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study.

Authors:  Michael J Mugavero; Margaret May; Heather J Ribaudo; Roy M Gulick; Sharon A Riddler; Richard Haubrich; Sonia Napravnik; Sophie Abgrall; Andrew Phillips; Ross Harris; M John Gill; Frank de Wolf; Robert Hogg; Huldrych F Günthard; Geneviève Chêne; Antonella D'Arminio Monforte; Jodie L Guest; Colette Smith; Javier Murillas; Juan Berenguer; Christoph Wyen; Pere Domingo; Mari M Kitahata; Jonathan A C Sterne; Michael S Saag
Journal:  J Acquir Immune Defic Syndr       Date:  2011-11-01       Impact factor: 3.731

6.  The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals.

Authors:  Maile Ray; Roger Logan; Jonathan A C Sterne; Sonia Hernández-Díaz; James M Robins; Caroline Sabin; Loveleen Bansi; Ard van Sighem; Frank de Wolf; Dominique Costagliola; Emilie Lanoy; Heiner C Bucher; Viktor von Wyl; Anna Esteve; Jordi Casbona; Julia del Amo; Santiago Moreno; Amy Justice; Joseph Goulet; Sara Lodi; Andrew Phillips; Rémonie Seng; Laurence Meyer; Santiago Pérez-Hoyos; Patricia García de Olalla; Miguel A Hernán
Journal:  AIDS       Date:  2010-01-02       Impact factor: 4.177

7.  Epidemiological characteristics and predictors of late presentation of HIV infection in Barcelona (Spain) during the period 2001-2009.

Authors:  Patricia Garcia de Olalla; Christian Manzardo; Maria A Sambeat; Inma Ocaña; Hernando Knobel; Victoria Humet; Pere Domingo; Esteve Ribera; Ana Guelar; Andres Marco; Maria J Belza; Josep M Miró; Joan A Caylà
Journal:  AIDS Res Ther       Date:  2011-07-06       Impact factor: 2.250

8.  Association of Patients' Geographic Origins with Viral Hepatitis Co-infection Patterns, Spain.

Authors:  Santiago Pérez Cachafeiro; Ana María Caro-Murillo; Juan Berenguer; Ferran Segura; Felix Gutierrez; Francesc Vidal; Maria Angeles Martinez-Perez; Julio Sola; Roberto Muga; Santiago Moreno
Journal:  Emerg Infect Dis       Date:  2011-06       Impact factor: 6.883

9.  Low CD4/CD8 ratio is associated with increased morbidity and mortality in late and non-late presenters: results from a multicentre cohort study, 2004-2018.

Authors:  Lourdes Domínguez-Domínguez; Marta Rava; José Antonio Iribarren; Santiago Moreno; Otilia Bisbal; Luis Lopez-Cortés; Joaquín Portilla; Daniel Podzamczer; Julián Olalla; Daniel Fuster; Rafael Rubio; Inmaculada Jarrín
Journal:  BMC Infect Dis       Date:  2022-04-15       Impact factor: 3.667

10.  All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010.

Authors:  Victoria Hernando; Belen Alejos; Susana Monge; Juan Berenguer; Lourdes Anta; David Vinuesa; Rosario Palacios; Roberto Muga; Santiago Moreno; Inma Jarrin
Journal:  BMC Infect Dis       Date:  2013-08-20       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.